Injectable Hydrogels for Minimally Invasive Joint Repair and Regeneration

1. Introduction

Joint health becomes a major concern in the mobility aspect and quality of life, as millions of people in the world face various pains and disabilities due to degenerative diseases of the joints [1,2]. These defects most often are a result of accidents, congenital malformations, or diseases of the skeleton, leading to progressively more pain and less function [1,3]. Arthroscopic examination of knee joints for definitive diagnosis and treatment of knee disorders shows that 60% of arthroscopies in patients display damage to the articular cartilage, whereas clinical symptoms are manifested in around 15% of the population over 60 years [3]. Although they have some general characteristics, all joints differ from each other: they can be described as either hinge joints like the knee or as ball-and-socket joints like the shoulder or hip. As time passes, joints get rubbed off because of arthritis or by joint use, causing pain, stiffness, and sometimes swelling [1,2,3]. Some diseases or injuries can limit blood flow into a bone [3]. The reduced blood flow to the bone means lesser growth and repair capability. These factors often make people consider taking up surgery options of joint replacement, especially after failing to provide relief through nonsurgical options like activity modifications, physical therapy, or medications [3,4].

Joint replacement operations, if understandably common procedures, encompass very important limitations and risks. For example, the surgery is not designed to regenerate a functional cartilage, but many symptoms can be alleviated temporarily [3]. Complications such as blood clots may also cause both pulmonary embolism and deep vein thrombosis, while 1-3% of hip replacement candidates also have a hip dislocation. Other issues include leg-length discrepancy which might require interventions on the part of the patient [3,4]. Given these discussed points, people increasingly turn to a new generation of minimally invasive modalities for the possible reduction of surgical risk in the pursuit of longer joint regeneration. Injectable hydrogels are opening up as a new alternative with the promise of restoring function and improving health in joints through fewer complications [5]. This review aims to discuss the properties, applications, and future perspectives of injectable hydrogels for minimally invasive joint repair and regeneration.

Injectable hydrogels have proved an outstanding minimal invasive application in biomedicine due to their unique characteristics that support tissue regeneration and minimize the risks and complications associated with the surgical procedures [6]. Hydrogels are hydrophilic, water-swollen polymer networks fabricated from both natural and synthetic polymers. Their adaptable composition enables chemical and physical crosslinking, causing them to gel instantly on in situ when injected [6,7]. This is very vital for medical applications as it guarantees smooth integration with surrounding tissues and minimizes invasive procedures. As said by Sigma-Aldrich, hydrogels could also function as delivery carriers for cells, bioactive molecules, and growth factors, because in a hydrated state their three-dimensional matrix resembles an extracellular environment, and enhances cell proliferation and differentiation in a repair process [5]. Moreover, biocompatibility and tunable features let them be tailored for particular mechanical and biochemical conditions concerning type of joints such as knees or hips. State-of-the-art progress has allowed therapeutics to be introduced into hydrogels, thus achieving prolonged drug release and targeted application at the site of injury, thereby further augmenting the regenerative capacity [8].

Besides these, hydrogels have more advantages over conventional surgical techniques. Unlike rigid implants, they also adapt to complex anatomical sites but remain usable in complex joint areas [9,10]. An added advantage is the minimal invasion delivery, which reduces tissue trauma, shortens recovery time, and decreases possible complications such as infection or thrombosis, which are common for open surgery [9,10,11]. This versatility indicates that hydrogel therapy might also prove useful in treating not just cartilage problems but other orthopedic pathologies, such as arthritis and synovial inflammation. The consequences raised with the continuing advancement of smart hydrogels, which can sense environmental stimuli like pH, temperature, or enzymes, further enhance their therapeutic applications [11,12]. Such development makes possible the exact control over the drug-release patterns, mechanical properties, and degradation rates, all suited to the specific necessities of each patient. Thus, injectable hydrogels come off as a very comprehensive and efficient answer and mind shifts toward how joint repair and regeneration take place [12].

2. Results and Discussion

The findings from preclinical and clinical studies highlight the significant potential of injectable hydrogels in advancing joint repair and regeneration. Preclinical animal models have demonstrated that hydrogels, particularly those enhanced with bioactive additives such as growth factors and stem cells, can promote cartilage repair by supporting cell viability, reducing inflammation, and stimulating extracellular matrix (ECM) production [8,9]. For instance, alginate-based hydrogels have shown improved integration and mechanical stability in cartilage defects, while thermally responsive hydrogels like PNIPAAm have enabled precise, localized delivery of therapeutic agents. Similarly, clinical trials have reported promising outcomes, with patients experiencing improved functional scores and reduced symptoms following hydrogel-based therapies [10,11]. However, variability in results across different studies underscores the need for optimization, particularly in weight-bearing joints where mechanical demands are higher. Challenges such as achieving uniform gel distribution, maintaining long-term biocompatibility, and scaling these innovations for broader clinical use remain significant [12]. Future studies should focus on refining hydrogel formulations to address these limitations while leveraging advanced techniques such as personalized medicine and dual-responsive hydrogels to enhance therapeutic efficacy. The transformative potential of these materials lies in their ability to offer minimally invasive, targeted solutions for joint repair, bridging the gap between regenerative medicine and clinical application.

2.1. Basic Properties

Injectable hydrogels, which can be natural and/or synthetic polymers, can be accordingly classified into classes with respect to chemical or physical crosslinking mechanism and have gained attention for their minimally invasive application via catheter or injection, eliminating the need for surgical procedures [11,12]. They could act as standalone therapeutic agent because they can render efficient tissue repair processes, devoid of any added cellular or molecular cargo. Such typical types of composite hydrogels that include natural materials-a fibrin and an alginate, and synthetic such poly (ethylene glycol)-render good biochemical and biomechanical properties suitable for cartilage regeneration [13]. Hydrogels can serve as drug depots and release therapeutic agents such as growth factors, cytokines, or stem cells in a sustained manner for localized tissue repair [10,11,12,13]. Those combined hydrogels were learned from cardiac repair studies, where they reduced tissue loss and improved structural strength and brought these efforts to joint repair. There are still many challenges to tackle, such as the optimization of degradation rates, therapeutic dosing, and overall efficacy in chronic injury models, in order to achieve successful clinical translation [14,15].

A key strength of injectable hydrogels is their tunable mechanical properties that can be adjusted to emulate the native extracellular matrix (ECM) for joint tissues [16,17]. By building crosslinking density, composition, and polymer ratios, hydrogels can be optimized to render the requisite stiffness and elasticity conditions for cartilage regeneration in a load-bearing mode. Because advanced hydrogels are incrementally designed in such a way as to include bioactive moieties, which effectuate chondrocyte differentiation and elicit matrix deposition, such as those of transforming growth factor-beta (TGF-β) and bone morphogenetic proteins (BMP-7) [18,19]. Preclinical studies indicated that such hydrogels containing growth factors are shown to influence cartilage repair through stimulation of cell proliferation and enhancement in matrix synthesis [20]. Hydrogels are also studied internally since anti-inflammatory agents are included, for example, interleukin-1 receptor antagonists or curcumin, where inflammation should be lessened within the joint microenvironment to improve outcomes about diseases like osteoarthritis [12]. Other advancements are those of self-healing hydrogels, which regain their structure after mechanical stress, for longevity in dynamic joint environments [20]. These advances, however, face obstacles before translation into clinical practice; such include factors like inhomogeneous gel distribution in complex joint structures and the long-term biocompatibility without causing adverse immune reaction [17,18].

2.2. Hydrogel Materials for Joint Repair

Naturally derived hydrogels, such as those formed from agarose, alginate, chitosan, hyaluronan, collagen, and fibrin, are attractive biomaterials for joint repair due to their biochemical similarity to cartilage and biodegradability through cell-secreted enzymes [21,22]. For instance, alginate and agarose hydrogels, derived from marine algae, undergo gelation under mild conditions and have been used extensively to study cartilage tissue engineering [7]. Clinical trials have shown promising outcomes, such as chondrocyte-seeded alginate-agarose hydrogels improving cartilage repair in patients with significant functional gains. Similarly, collagen hydrogels, particularly those from type I and type II collagen, promote chondrocyte proliferation and extracellular matrix (ECM) production, with type II collagen supporting enhanced chondrogenic differentiation of mesenchymal stem cells (MSCs) [7]. However, these materials often lack the mechanical integrity needed to withstand physiological loads, and modifications such as crosslinking or combining with synthetic polymers are necessary to enhance their stability and function [21,22]. Shown below, Table 1 summarizes the key materials, including their biochemical and mechanical properties, advantages, and limitations in cartilage regeneration.

The recent advancements in hydrogel materials for joint repair are fibrin, hyaluronan, chitosan, and synthetic polymers like poly (vinyl alcohol)(PVA). Fibrin hydrogels have an excellent adhesion to tissue and facilitate the formation of cartilage, but they possess very inferior mechanical properties [23]. Hyaluronan hydrogels are obtained from glycosaminoglycans and promote cartilage formation; their degradation could be controlled for application in nonweight-bearing defects [7]. Chitosan is structural homolog to cartilage glycosaminoglycans derived from chitin, which has proved a success in preclinical and clinical models to repair cartilage defects [23,24]. Synthetic hydrogels such as PVA have better mechanical properties, including compressive modulus and frictional behavior, closer to those of articular cartilage. The PVA hydrogels are considered to be durable, self-lubricating, and swell well, making suitable candidates for weight-bearing joints, and they have been highly characterized for cartilage replacement [16]. Yet, challenges facing these treatments involved achieving biocompatibility and avoiding an immune response, which proved important for clinical translation.

2.3. Bioactive Additives

In addition to the growth factors and stem cells, bioactive additives further enhance the regenerative potential of injectable hydrogels for joint repair [25]. Growth factors, such as transforming growth factor-beta (TGF-β); bone morphogenetic proteins, especially BMP-7; and insulin-like growth factor-1 (IGF-1), are included in hydrogels so that stimulation of proliferatory and matrix protein synthesis functions such as ECM production and cartilage repair is achieved by chondrocytes [7]. Localized and sustained signals stimulate tissue healing and minimize side effects. Thus, for example, hydrogels loaded with TGF-β have the property of improving chondrogenic differentiation in mesenchymal stem cells (MSCs) and cartilage matrix deposition in preclinical models [3]. Cells also act as bioactive agents while serving as source for regenerative cells if encapsulated by hydrogels. However, in the case of MSCs, they not only secrete anti-inflammatory cytokines and growth factors but also modulate immune responses and differentiate into chondrocytes, thus accelerating cartilage repair. Further, hydrogels may be designed to achieve a time-controlled release of these bioactive additives so that their bioavailability matches with the healing process [26,27]. Recent developments also consist of dual-delivery systems that provide multiple growth factors for synergistic actions and hydrogels that mimic a native microenvironment for further optimization of stem cell viability and function [28]. However, ongoing research is needed to address other challenges such as uniform distribution, premature degradation, and scale-up for clinical use.

2.4. Thermal or pH Responsive Hydrogels

Thermal and pH-responsive hydrogels are some cleverer biomaterials with potential to improve the accuracy of drug delivery in repairing and regenerating joints. These types of sensitive hydrogels can be induced through changing temperature or changing pH, for example, into either releasing or locally sequestering drugs, growth factors, or cells that have been embedded within them [29]. Typical examples of thermal responsive hydrogels include those that have poly(N-isopropylacrylamide) (PNIPAAm), which also exhibit the sol-gel transition or the liquid-state conditions of temperature close to desired physiological temperature during body temperature application [29]. In contrast, such materials can be injected at room temperature but will solidify in a gel matrix at body temperature, thus retaining therapeutic agents at the target site while preventing infusions through systemic action. On the other hand, the degree of swelling by such hydrogels can be accountable for triggering a break in the acid microenvironments associated with inflammation in most joint diseases. This is primarily chitosan and poly (acrylic acid); thus, hydrogels use these as materials to induce their pH-sensitive delivery system of bioactive agents as shown in Table 2 below [30].

Consequently, dual-responsive thermal and pH-sensitive hydrogels offer excellent prospects for coping with differential and dynamic environments of joint injuries. By tuning these hydrogels for slow degradation and sustained release, it is possible to ensure that therapeutic effect targets the need over time as healing occurs further [29,30]. Sensitivity to such stimuli can even be combined with regenerative activity based on bioactive additives such as growth factors or even anti-inflammatory agents. Nevertheless, though such hydrogels have been built, a real hurdle opens up in the application of them into clinical uses. This can be in terms of the drug release pattern from the gel matrix and drug distribution uniformity into that matrix, non-cytotoxic and non-allergic degradation products, and production scaling to clinical trial experience [31]. Irrespective of all these, such intelligent hydrogels are set to revolutionize the field for specific yet minimally invasive treatments in joint repair and have thus become a keen area of attention in research in regenerative medicine.

2.5. In vivo Testing

Studies in vivo using animal-models have been pivotal in assessing the delivery and efficacy of injectable hydrogels for repair of cartilage, specifically providing a precedent for development and pre-clinical testing [32]. A case in point is the report on thermally triggered injectable hydrogel in which it was applied to its site of delivery to prove the biomicompatibility and potential of this promising material in enhancing bone formation and migration of cells to merge with established bone, suggesting itself as a means of safe and effective bone repair [8]. The same trend goes for the injectable decellularized cartilage matrix hydrogels encapsulated mesenchymal stem cells that have recently been reported to provide effective cartilage defect repair [33]. The hydrogels also supported cell viability and proliferation in vitro in combination leading to improved cartilage regeneration in vivo [35]. With precisely the same nature as the real-extracellular matrix with the avowed objective of aiding tissue regeneration, these findings bring about an implication of injectable hydrogels as minimally invasive treatments for cartilage repair [34,35]. Though, animal models may be very beneficial, further studies and clinical tests are required to prove the safety and efficacy of these hydrogels for human application [35].

2.6. Challenges

Even though substantial progress has been made, there are many obstacles in the development and translation of injectable hydrogels for joint repair. One such limitation concerns the mechanical properties of the hydrogels. For example, the hydrogels do not completely replicate the strength and durability of cartilages of native origin [8]. This is a setback to applications in weight-bearing joints, in which an hydrogel is expected to endure repeated mechanical stresses without any degradation or failure. Modifications like reinforcement of hydrogels with synthetic polymers or nanoparticles may improve these properties, but in most cases, it compromises biocompatibility or biodegradability of the material [3]. Then again, the hydrogel has been uniformly distributed within the complex structural arrangement of the joints. It is one of the major impediments in application for minimally invasive interventions, as uneven spreading within a joint can lead to poor integration with surrounding tissue [33,34].

The immune response and biocompatibility of hydrogels are yet other major challenges. Naturally derived materials sometimes carry the risk of immunogenicity, and synthetic polymers may release some toxic by-products in the course of degradation [25]. Ensuing their long-term biocompatibility will avert such adverse reactions as inflammation or fibrosis that may hinder regeneration of tissue. The production and reproducibility of these hydrogel materials over large scale are still very significant barriers. Establishing standardised processes for manufacturing to ensure the quality standard is consistent among the batches is vital for regulatory approval as well as clinical use [36]. It should be noted, however, that while preclinical studies using animal models have produced encouraging results, such evidence usually does not translate into humans because of differences in joint anatomy and physiology. More robust, large-scale clinical trials and advanced models that better mimic the human clinical situation will be needed to bridge this gap [36].

2.7. Future Directions

Next-generation materials are likely to be developed to address the limitations of current injectable hydrogels for joint repair and expand their future therapeutic potential. One promising direction may be the introduction of multi-functional combining mechanical strength with bioactivity [25]. This could include producing hydrogels capable of both bearing loads and providing therapeutic agents such as growth factors or anti-inflammatory drugs. Advanced 3D bioprinting and novel techniques in additive manufacture should lead the way toward revolutionizing the personalization of hydrogels themselves by bringing about patient-specific implant designs suitable for individual joint deficiencies [26,27]. Innovations such as dual responses such as heat and pH may even improve precision in drug delivery to the damaged environment as it dynamically adapts to the injured microenvironment [30]. Such advancements, as paired with self-healing, can improve long-term durability in weight-bearing joints.

Then there is the clinical translation of much hydrogel technology with which one would pledge progress. Despite preclinical animal studies demonstrating that hydrogels hold great promise for cartilage regeneration and inflammation, the challenge of human applications remains huge. Extensive clinical trials with large numbers of patients from various backgrounds would be necessary to establish safety, efficacy and scalability. Bringing hydrogels into the regenerative medicine avenues of gene-editing or stem-cell therapies might add yet a completely different dimension into the possibilities of joint repair by supplementing cell survivability and integration with native tissues [8]. Alongside these, ethical and regulatory considerations would also have needed attention for effecting larger-scale deployments.

3. Conclusions

These hydrogels derived from injectable biomaterials are a promising new trend in minimally invasive joint repair which involves advanced biomaterials combined with principles of regenerative medicine. More specifically, based on natural and synthetic polymers, injectable hydrogels mimic the extracellular cartilage matrix for local, sustained release of drugs such as growth factors and stem cells. Preclinical and early clinical studies have indicated their potential for promoting cartilage regeneration, reducing inflammation, and improving joint function. Some of the innovations such as thermal and pH-sensitive hydrogels have further improved the adaptability for fine-tuning drug release triggered by changes in the environment. However, challenges remain, such as optimizing the mechanical properties for weight-bearing joints, long-term biocompatibility, and cost-effective production standardization for clinical scalability.

Future research could address these challenges via the use of emerging technologies, such as 3D bioprinting, self-healing hydrogels, and personalized medicine. Before implementing these innovations in practice, it is crucial to engage into an interdisciplinary collaborative effort of material scientists, bioengineers, and clinicians. Injectable hydrogels are highly promising in treating joint repair in the future because they will provide highly targeted patient-specific treatments for minimizing invasive surgeries while increasing favorable outcomes for patients in orthopedics and regenerative medicine. Bridging cutting-edge bio-materials with clinical practice will redefine how standards in care can be set for joint repair and regeneration.

4. Methodology

This review was conducted by systematically analyzing peer-reviewed literature to explore the properties, applications, and challenges of injectable hydrogels for joint repair and regeneration. Databases such as PubMed, ScienceDirect, and Google Scholar were utilized to identify relevant studies published between [1999–2024]. Articles were selected based on their relevance, scientific rigor, and contributions to understanding hydrogels' properties, preclinical and clinical outcomes, and future directions. Additionally, information on emerging technologies and challenges was synthesized from high-impact reviews and experimental studies. The data presented in this paper summarize findings from both preclinical animal models and clinical trials, with a focus on translating these innovations into practical orthopedic applications.